Precision Medicine with TGF-β Inhibition Using Tumor Explants: Comment on “Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor” by N. Sumru Bayin et al.
In a new report, Bayin et al. described an ex vivo explant model to test the patient-specific response to transforming growth factor-β inhibition in high-grade gliomas.
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Neoplasia Press
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156519/ |